The Holly and the IV - When Pharma and Christmas combine
At this time of year science may play second fiddle to opening presents and drinking mulled wine, but in-Pharmatechnologist.com has leveled the field with its interactive nativity card.
At this time of year science may play second fiddle to opening presents and drinking mulled wine, but in-Pharmatechnologist.com has leveled the field with its interactive nativity card.
If the Coca-Cola truck can battle the snow each Christmas so too can drug logistics firms using technology, contingency plans and sometimes a good old-fashioned shovel, distributors say.
Molecular Profiles has been selected to develop and analyse paediatric formulations in a UK-wide consortium led by AstraZeneca.
A private equity investor has sold its stake in CRO Chiltern leading to a restructured ownership the firm says will encourage expansion.
Importing drugs and ingredients from the East is not a new idea, but did the practice start 2000 years ago in Judea?
The EMA and US FDA will conduct joint site inspections and share the results of assessments of bioequivalence data for generic drugs under an accord announced last night.